Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC18701 Hellebrin

    NSC 93134

    Hellebrin is a cardiac glycoside that potently inhibits the Na+/K+-ATPase by binding to it and blocking its non-canonical function as a receptor for cardiac glycosides. Hellebrin  Chemical Structure
  3. GC39266 Hematein Hematein is a oxidation product of hematoxylin acted as a dye. Hematein is an allosteric casein kinase II inhibitor with an IC50 of 0.74 μM. Hematein inhibits Akt/PKB Ser129 phosphorylation, the Wnt/TCF pathway and increases apoptosis in lung cancer cells. Hematein  Chemical Structure
  4. GC63902 Hematoporphyrin monomethyl ether Hematoporphyrin monomethyl ether, second generation of porphyrin-related photosensitizer, is characterized by its single form, high yield of singlet oxygen, high selectivity, and low toxicity, which has been widely used in the diagnosis and treatment of various tumors, including lung cancer, bladder cancer, and nevus flammeus and brain glioma. Hematoporphyrin monomethyl ether  Chemical Structure
  5. GC43816 Heptelidic Acid

    Avocettin, BRN 5091359, FO-4443, Koningic Acid

    Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a key enzyme in carbohydrate metabolism, reversibly catalyzes the conversion of GAP to 1,3-bisphosphoglycerate and NAD+. Heptelidic Acid  Chemical Structure
  6. GC18796 Herbicidin A Herbicidin A is an adenine nucleoside antibiotic originally isolated from S. Herbicidin A  Chemical Structure
  7. GC40067 Herbimycin C

    Antibiotic TAN 420D

    Herbimycin C is a bacterial metabolite originally isolated from S. Herbimycin C  Chemical Structure
  8. GC33092 Hesperin

    6-MSITC

    An isothiocyanate with diverse biological activities Hesperin  Chemical Structure
  9. GN10248 Hesperitin

    (–)-Hesperetin, (S)-Hesperetin, NSC 57654, (–)-3',5,7-Trihydroxy-4'-methoxyflavanone

    Hesperitin  Chemical Structure
  10. GC15178 Hexamethonium Bromide Selective antagonist of neuronal-type nicotinic AChR Hexamethonium Bromide  Chemical Structure
  11. GC38099 Higenamine Higenamine (Norcoclaurine), a β2-AR agonist, is a key component of the Chinese herb aconite root that prescribes for treating symptoms of heart failure in the oriental Asian countries. Higenamine  Chemical Structure
  12. GC38237 Higenamine hydrochloride Higenamine hydrochloride (Norcoclaurine hydrochloride), a β2-AR agonist, is a key component of the Chinese herb aconite root that prescribes for treating symptoms of heart failure in the oriental Asian countries. Higenamine hydrochloride  Chemical Structure
  13. GC11302 Hinokitiol

    NSC 18804, β-Thujaplicin, 4-isopropyl Tropolone

    A tropolone with diverse biological activities Hinokitiol  Chemical Structure
  14. GC36229 Hirsutine Hirsutine, an indole alkaloid of Uncaria rhynchophylla, exhibits anti-cancer activity. Hirsutine  Chemical Structure
  15. GC31739 Hispidol ((Z)-Hispidol)

    (Z)-Hispidol

    Hispidol ((Z)-Hispidol) ((Z)-Hispidol ((Z)-Hispidol)) is a potential therapeutic for inflammatory bowel disease; inhibits TNF-α induced adhesion of monocytes to colon epithelial cells with an IC50 of 0.50 μM. Hispidol ((Z)-Hispidol)  Chemical Structure
  16. GC45473 Histone H2BK12ac (1-22)-GGK-biotin amide (trifluoroacetate salt) Histone H2BK12ac (1-22)-GGK-biotin amide (trifluoroacetate salt)  Chemical Structure
  17. GC32807 HJC0152 hydrochloride An orally bioavailable inhibitor of STAT3 HJC0152 hydrochloride  Chemical Structure
  18. GC17023 HLCL-61 HLCL-61 is a first-in-class inhibitor of protein arginine methyltransferase 5 (PRMT5). HLCL-61  Chemical Structure
  19. GC61608 HLI373 dihydrochloride HLI373 dihydrochloride is an efficacious Hdm2 inhibitor. HLI373 dihydrochloride  Chemical Structure
  20. GC62594 hnRNPK-IN-1 hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities. hnRNPK-IN-1  Chemical Structure
  21. GC16208 HO-3867 STAT3 inhibitor, selective HO-3867  Chemical Structure
  22. GC31692 Homoplantaginin

    Hispidulin-7-O-D-glucoside

    A flavonoid glycoside with antioxidant and anti-inflammatory activities Homoplantaginin  Chemical Structure
  23. GC11574 HPOB HDAC6 inhibitor, potent and selective HPOB  Chemical Structure
  24. GC32280 HS-1371 A RIPK3 inhibitor HS-1371  Chemical Structure
  25. GC16713 HS-173 novel PI3K inhibitor HS-173  Chemical Structure
  26. GC11973 HSP990 (NVP-HSP990)

    NVP-HSP990

    HSP990 (NVP-HSP990) is a potent and selective Hsp90 inhibitor, with IC50 values of 0.6, 0.8, and 8.5 nM for Hsp90α, Hsp90β, and Grp94, respectively. HSP990 (NVP-HSP990)  Chemical Structure
  27. GC13074 HU 211 NMDA antagonist, novel and non-competitive HU 211  Chemical Structure
  28. GC68404 Human PD-L1 inhibitor IV Human PD-L1 inhibitor IV  Chemical Structure
  29. GC64485 HXR9 hydrochloride HXR9 hydrochloride is a cell-permeable peptide and a competitive antagonist of HOX/PBX interaction. HXR9 hydrochloride antagonizes the interaction between HOX and a second transcrip-tion factor (PBX), which binds to HOX proteins in paralogue groups1 to 8. HXR9 hydrochloride selectively decreases cell proliferation and promotes apoptosis in cells with a high level of expression of the HOXA/PBX3 genes, such as MLL-rearranged leukemic cells. HXR9 hydrochloride  Chemical Structure
  30. GC36270 Hydrolyzed Fumonisin B1

    Aminopentol

    Hydrolyzed Fumonisin B1 (Aminopentol) is the backbone and main hydrolysis product of the mycotoxin Fumonisin B1. Hydrolyzed Fumonisin B1  Chemical Structure
  31. GC49130 Hydroxy Celecoxib An inactive metabolite of celecoxib Hydroxy Celecoxib  Chemical Structure
  32. GC16843 Hydroxyurea

    NCI C04831, NSC 32065

    DNA synthesis inhibitor Hydroxyurea  Chemical Structure
  33. GN10217 Hypaconitine Hypaconitine  Chemical Structure
  34. GN10302 Hypericin

    NSC 407313

    Hypericin  Chemical Structure
  35. GC36283 Hypocrellin B A fungal metabolite Hypocrellin B  Chemical Structure
  36. GC49479 Hypoxanthine-d4

    6-Hydroxypurine-d4

    An internal standard for the quantification of hypoxanthine Hypoxanthine-d4  Chemical Structure
  37. GC19194 IACS-10759

    IACS-10759 (IACS-010759) is an oxidative phosphorylation inhibitor, IACS-10759 is a potent inhibitor of complex I of oxidative phosphorylation ( OXPHOS )

    IACS-10759  Chemical Structure
  38. GC36286 IACS-10759 Hydrochloride

    IACS-10759 hydrochloride

    IACS-10759 Hydrochlorideis an orally active, potent mitochondrial complex I of oxidative phosphorylation (OXPHOS) inhibitor. IACS-10759 Hydrochlorideinhibits proliferation and induces apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS. IACS-10759 Hydrochloride has the potential for relapsed/refractory AML and solid tumors research. IACS-10759 Hydrochloride  Chemical Structure
  39. GC19197 IB-MECA

    CF-101, IB-MECA

    IB-MECA (IB-MECA) is a first-in-class, orally active and selective A3 adenosine receptor (A3AR) agonist. IB-MECA  Chemical Structure
  40. GC13246 Ibandronate sodium Ibandronate sodium is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis. Ibandronate sodium  Chemical Structure
  41. GC19195 Iberdomide

    CC-220

    Iberdomide (CC-220) is a cereblon modulator with an IC50 of 60 nM. Iberdomide  Chemical Structure
  42. GC17287 Iberin

    NSC 321801

    induces the expression of phase II detoxification enzymes, including quinone reductase and glutathione S-transferase Iberin  Chemical Structure
  43. GC14503 IC261

    SU5607

    CK1 inhibitor IC261  Chemical Structure
  44. GC38096 Icaritin Icaritin is a prenylflavonoid derivative obtained from the Epimedium genus. Icaritin  Chemical Structure
  45. GC32762 Icaritin (Anhydroicaritin) Icaritin (Anhydroicaritin) (Anhydroicaritin) is a prenylflavonoid derivative from Epimedium brevicornuMaxim. and potently inhibits proliferation of K562 cells (IC50 of 8 μM) and primary CML cells (IC50 of 13.4 μM for CML-CP and 18 μM for CML-BC). Icaritin (Anhydroicaritin) can regulate MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings, also enhances osteogenesis[3. Icaritin (Anhydroicaritin)  Chemical Structure
  46. GC62626 ICCB-19 hydrochloride ICCB-19 hydrochloride is a TRADD (TNFRSF1A associated via death domain) inhibitor. ICCB-19 hydrochloride  Chemical Structure
  47. GC61414 ICCB280 ICCB280 is a potent inducer of C/EBPα. ICCB280 exhibits anti-leukemic properties including terminal differentiation, proliferation arrest, and apoptosis through activation of C/EBPα and affecting its downstream targets (such as C/EBPε, G-CSFR and c-Myc). ICCB280  Chemical Structure
  48. GC19198 iCRT3 iCRT3 is an inhibitor of both Wnt and β-catenin-responsive transcription. iCRT3  Chemical Structure
  49. GC19411 IITZ-01 IITZ-01 is a potent lysosomotropic autophagy inhibitor with single-agent antitumor activity, with an IC50 of 2.62 μM for PI3Kγ. IITZ-01  Chemical Structure
  50. GC43894 IKK2 Inhibitor VI

    5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide

    Inhibitor of NF-κB kinase 2 (IKK2, also known as IKKβ) acts as part of an IKK complex in the canonical NF-κB pathway, phosphorylating inhibitors of NF-κB (IκBs) to initiate signaling.

    IKK2 Inhibitor VI  Chemical Structure
  51. GC38566 Ilexsaponin A Ilexsaponin A, isolated from the root of Ilex pubescens, attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway. Ilexsaponin A  Chemical Structure
  52. GC41340 Illudin M

    DR-15977, (-)-Illudin M, NSC 400978, NSC 626370

    Illudin M is a cytotoxic sesquiterpene from the fungus O. Illudin M  Chemical Structure
  53. GC12046 iMAC2 iMAC2  Chemical Structure
  54. GC65168 Imifoplatin

    PT-112

    Imifoplatin (PT-112) is a platinum-based agent belonging to the phosphaplatin family. Imifoplatin exhibits antineoplastic activity. Imifoplatin  Chemical Structure
  55. GC19199 Importazole

    IPZ

    Importazole is a small molecule inhibitor of the nuclear transport receptor importin-β. Importazole  Chemical Structure
  56. GC14755 Inauhzin

    INZ

    SIRT1 inhibitor Inauhzin  Chemical Structure
  57. GC19200 INCB-057643 INCB-057643 is a novel, orally bioavailable BET inhibitor. INCB-057643  Chemical Structure
  58. GC17866 INCB28060

    Capmatinib, INC 280

    INCB28060 (INC280; INCB28060) is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor (IC50=0.13 nM). INCB28060 can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. INCB28060 potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. INCB28060 is largely metabolized by CYP3A4 and aldehyde oxidase. INCB28060  Chemical Structure
  59. GC38213 Incensole Acetate

    Incensol Acetate

    Incensole acetate is a main constituent of Boswellia carterii resin, has neuroprotective effects against neuronal damage in traumatic and ischemic head injury. Incensole Acetate  Chemical Structure
  60. GC36308 Indibulin

    D-24851, ZIO 301

    An inhibitor of microtubule assembly Indibulin  Chemical Structure
  61. GC12975 Indirubin

    C.I. 73200, Couroupitine B, Indigopurpurin, NSC 105327

    A cyclin-dependent kinases and GSK-3β inhibitor Indirubin  Chemical Structure
  62. GC49670 Indium (III) thiosemicarbazone 5b An anticancer agent Indium (III) thiosemicarbazone 5b  Chemical Structure
  63. GC61948 Inecalcitol Inecalcitol (TX 522), a unique vitamin D3 analog, is an orally active vitamin D receptor (VDR) agonist with a Kd of 0.53 nM. Inecalcitol can induce cell apoptosis and has potent anticancer activities. Inecalcitol  Chemical Structure
  64. GC19533 Infliximab Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab  Chemical Structure
  65. GC61776 Ingenol 3,20-dibenzoate Ingenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate  Chemical Structure
  66. GC10334 INH6 Hec1/Nek2 inhibitor, potent INH6  Chemical Structure
  67. GC48387 Inostamycin A A bacterial metabolite with anticancer activity Inostamycin A  Chemical Structure
  68. GC52472 Inostamycin A (sodium salt)

    Inostamycin

    A bacterial metabolite with anticancer activity Inostamycin A (sodium salt)  Chemical Structure
  69. GC15148 Ionomycin calcium salt

    Lonomycin is a selective calcium ionophore derived from S. conglobatus that mobilizes intracellular calcium stores.

    Ionomycin calcium salt  Chemical Structure
  70. GC15446 Ionomycin free acid Ionomycin free acid (SQ23377) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus. Ionomycin free acid  Chemical Structure
  71. GC46027 IP7e

    Isoxazolo-pyridinone 7e

    An activator of Nurr1 signaling IP7e  Chemical Structure
  72. GC52175 IQA

    CGP 029482

    IQA  Chemical Structure
  73. GC10467 Irbesartan

    BMS 186295, SR 47436

    Angiotensin II inhibitor Irbesartan  Chemical Structure
  74. GC12962 Isatin endogenous monoamine oxidase inhibitor Isatin  Chemical Structure
  75. GC63386 Isatuximab Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions. Isatuximab  Chemical Structure
  76. GC64767 ISIS 104838 ISIS?104838?is an antisense oligonucleotide drug that reduces the production of tumor necrosis factor (TNF-alpha),?a substance that contributes to joint pain and swelling in rheumatoid arthritis. ISIS 104838  Chemical Structure
  77. GN10666 Isoalantolactone

    (+)-Isoalantolactone, NSC 241036

    Isoalantolactone  Chemical Structure
  78. GC13795 Isobavachalcone

    Corylifolinin, IBC

    A chalcone and flavonoid with diverse biological activities Isobavachalcone  Chemical Structure
  79. GC48900 Isocurcumenol

    (+)-Isocurcumenol

    A sesquiterpene with diverse biological activities Isocurcumenol  Chemical Structure
  80. GC40901 Isogarcinol

    Cambogin

    Isogarcinol is a natural polyisoprenylated benzophenone first isolated from plant species in the genus Garcinia. Isogarcinol  Chemical Structure
  81. GC38220 Isoliensinine Isoliensinine  Chemical Structure
  82. GN10088 Isoliquiritigenin

    GU 17, ILQ, ISL

    Isoliquiritigenin  Chemical Structure
  83. GC60949 Isolongifolene Isolongifolene ((-)-Isolongifolene) is a tricyclic sesquiterpene isolated from Murraya koenigii. Isolongifolene  Chemical Structure
  84. GC48618 Isonanangenine B

    SF002-96-1

    A drimane sesquiterpene lactone Isonanangenine B  Chemical Structure
  85. GC36343 Isosilybin A Isosilybin A, a flavonolignan isolated from silymarin, has anti-prostate cancer (PCA) activity. Isosilybin A inhibits proliferation and induces G1 phase arrest and apoptosis in cancer cells, which activates apoptotic machinery in PCA cells via targeting Akt-NF-κB-androgen receptor (AR) axis. Isosilybin A  Chemical Structure
  86. GC36344 Isosilybin B Isosilybin B, a flavonolignan isolated from silymarin, has anti-prostate cancer (PCA) activity via inhibiting proliferation and inducing G1 phase arrest and apoptosis. Isosilybin B causes androgen receptor (AR) degradation. Isosilybin B  Chemical Structure
  87. GC43922 Isovaleryl-L-carnitine (chloride)

    CAR 5:0, C5:0 Carnitine, L-Carnitine isovaleryl ester, L-Isovalerylcarnitine

    Isovaleryl-L-carnitine (chloride), a product of the catabolism of L-leucine, is a potent activator of the Ca2+-dependent proteinase (calpain) of human neutrophils. Isovaleryl-L-carnitine (chloride)  Chemical Structure
  88. GC13394 Ispinesib (SB-715992)

    SB-715992

    Ispinesib (SB-715992) is a specific inhibitor of kinesin spindle protein (KSP), with a Ki app of 1.7 nM. Ispinesib (SB-715992)  Chemical Structure
  89. GC16869 Ixabepilone

    Azaepothilone B, BMS-247550

    A broad-spectrum anticancer agent Ixabepilone  Chemical Structure
  90. GC41645 Jacaric Acid

    8(Z),10(E),12(Z)-Octadecatrienoic Acid

    Jacaric acid is a conjugated polyunsaturated fatty acid first isolated from seeds of Jacaranda plants. Jacaric Acid  Chemical Structure
  91. GN10645 Jaceosidin Jaceosidin  Chemical Structure
  92. GC62665 JAK2/FLT3-IN-1 TFA JAK2/FLT3-IN-1 (TFA) is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. JAK2/FLT3-IN-1 (TFA) has anti-cancer activity. JAK2/FLT3-IN-1 TFA  Chemical Structure
  93. GC34634 JG-98 JG-98, an allosteric heat shock protein 70 (Hsp70) inhibitor, which binds tightly to a conserved site on Hsp70 and disrupts the Hsp70-Bag3 interaction. JG-98 shows anti-cancer activities affecting both cancer cells and tumor-associated macrophages. JG-98  Chemical Structure
  94. GC15603 JIB-04

    JHDM Inhibitor VII, NSC 693627

    Jumonji histone demethylase inihibitor JIB-04  Chemical Structure
  95. GC12117 JNJ-26854165 (Serdemetan)

    Serdemetan

    An antagonist of MDM2 action JNJ-26854165 (Serdemetan)  Chemical Structure
  96. GC12612 JNJ-7706621

    JNJ7706621, JNJ 7706621

    A dual inhibitor of CDKs and Aurora kinases JNJ-7706621  Chemical Structure
  97. GC18734 JS-K JS-K is a nitric oxide (NO) donor that reacts with glutathione to generate NO at physiological pH. JS-K  Chemical Structure
  98. GC38082 JTE-013 A selective S1P2 receptor antagonist JTE-013  Chemical Structure
  99. GC50280 JX 06

    NSC 402538

    Potent and selective pyruvate dehydrogenase kinase (PDK) 1/2/3 inhibitor JX 06  Chemical Structure
  100. GC16167 K 858 K858 Racemic is an ATP-uncompetitive inhibitor of kinesin Eg5 with an IC50 of 1.3 μM. K 858  Chemical Structure
  101. GC15281 K-252c

    Staurosporinone

    Protein kinase inhibitor K-252c  Chemical Structure

Items 1001 to 1100 of 2214 total

per page
  1. 9
  2. 10
  3. 11
  4. 12
  5. 13

Set Descending Direction